연구동향 분석

Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design

성현환 주명수 김준철 김장환 이규성 2020년

논문상세정보
인용/피인용
' Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Lower urinary tract symptoms
  • Naftopidil
  • Neurogenic
  • urinary bladder
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
121 0

0.0%

' Efficacy and Safety of Naftopidil in Patients With Neurogenic Lower Urinary Tract Dysfunction: An 8-Week, Active-Controlled, Stratified-Randomized, Double-Blind, Double-Dummy, Parallel Group, Noninferiority, Multicenter Design' 의 참고문헌

  • α1DAdrenoceptor blockade increases voiding efficiency by improving external urethral sphincter activity in rats with spinal cord injury
    Ishida H [2016]
  • alpha1-adrenoceptors and bladder function
    Andersson K [1999]
  • Urodynamic effects of alpha1-blocker tamsulosin on voiding dysfunction in patients with neurogenic bladder
    Kakizaki H [2003]
  • Translation and Linguistic Validation of the Korean Version of the “Benefit, Satisfaction, and Willingness to Continue” Questionnaire for Patients With Overactive Bladder
    조성용 [2016]
  • Terazosin for vesicosphincter dyssynergia in spinal cordinjured male patients
    Bennett JK [2000]
  • Tamsulosin: efficacy and safety in patients with neurogenic lower urinary tract dysfunction due to suprasacral spinal cord injury
    Abrams P [2003]
  • Selective alpha adrenergic antagonist reduces severity of transient hypertension during sexual stimulation after spinal cord injury
    Phillips AA [2015]
  • Role of supraspinal alpha1-adrenoceptors for voiding in conscious rats with and without bladder outlet obstruction
    Gu BJ [2002]
  • Prospective evaluation of terazosin for the treatment of autonomic dysreflexia
  • Predictive factors for the effect of the α1-D/A adrenoceptor antagonist naftopidil on subjective and objective criteria in patients with neurogenic lower urinary tract dysfunction
    Takeda M [2011]
  • Non-surgical urologic management of neurogenic bladder after spinal cord injury
    Romo PGB [2018]
  • Naftopidil, a novel alpha1-adrenoceptor antagonist, displays selective inhibition of canine prostatic pressure and high affinity binding to cloned human alpha1-adrenoceptors
    Takei R [1999]
  • Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
    Hwang EC [2018]
  • Modulation of bladder alpha1-adrenergic receptor subtype expression by bladder outlet obstruction
    Hampel C [2002]
  • KMD-3213, a novel, potent, alpha 1a-adrenoceptor-selective antagonist:characterization using recombinant human alpha 1-adrenoceptors and native tissues
    Shibata K [1995]
  • Combinational effects of muscarinic receptor inhibition and β3-adrenoceptor stimulation on neurogenic bladder dysfunction in rats with spinal cord injury
    Wada N [2017]
  • Combination drug therapy improves compliance of the neurogenic bladder
    Cameron AP [2009]
  • Autonomic dysreflexia after spinal cord injury : systemic pathophysiology and methods of management
    Eldahan KC [2018]
  • Alpha1-adrenoceptor subtypes and lower urinary tract symptoms
    Schwinn DA [2008]
  • Alpha1-adrenergic receptors in human spinal cord : specific localized expression of mRNA encoding alpha1-adrenergic receptor subtypes at four distinct levels
    Smith MS [1999]
  • Alpha1-adrenergic receptor subtypes in human detrusor
    Malloy BJ [1998]
  • Alpha-1 Adrenergic Receptor Blockers for the Treatment of Lower Urinary Tract Symptoms in Women: A Systematic Review and Meta-Analysis
    김도경 [2019]
  • Alpha 1-and alpha 2-adrenoceptors in the smooth muscle of isolated rabbit urinary bladder and urethra
    Ueda S [1984]
  • A study of the alpha-1adrenoceptor blocker prazosin in the prophylactic management of autonomic dysreflexia in high spinal cord injury patients
    Krum H [1992]